Current care strategies for Duchenne muscular dystrophy [Aktuelle Betreuungsstrategien bei Duchenne-Muskeldystrophie]

被引:0
|
作者
Fujak A. [1 ]
Haaker G. [1 ]
Funk J. [1 ]
机构
[1] Orthopädische Klinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Deutschland, Rathsberger Str. 57, Erlangen
来源
Der Orthopäde | 2014年 / 43卷 / 7期
关键词
Kontrakturen; Skoliose; Behandlung; Orthopädietechnische Hilfsmittel; Rehabilitation; Contractures; Scoliosis; Treatment; Orthopedic technical aids; Rehabilitation;
D O I
10.1007/s00132-013-2217-7
中图分类号
学科分类号
摘要
BACKGROUND: The medical care of patients with Duchenne muscular dystrophy (DMD) is an interdisciplinary and multifaceted task. The vast majority of those affected show a nearly constant course which is reflected in a corresponding stage-oriented treatment concept. Although there is still no causal therapy available for DMD, the course and in particular the quality of life of patients can be decisively improved by established medical practices.THERAPEUTIC STRATEGIES: The orthopedic problems of DMD patients include contractures of the upper and lower extremities as well as sitting instability due to progressive scoliosis with pelvic imbalance. The orthopedic treatment incorporates conservative measures, such as physiotherapy, provision of orthotic devices and wheelchairs as well as surgery to resolve contractures of the lower extremities and surgical stabilization of the spine. Furthermore, in these patients orthopedic surgeons and trauma surgeons are confronted with the treatment and prophylaxis of fractures induced by osteoporosis. An early onset of glucocorticoid therapy markedly delays the loss of motor abilities.TREATMENT ASPECTS: An important aspect in the care of DMD patients is the timely prophylaxis and treatment of respiratory insufficiency with regular sessions of breathing therapy, learning breathing and coughing techniques and the sufficiently early start of non-invasive mechanically assisted ventilation. Of similar relevance are also the early recognition and cardioprotective treatment of cardiomyopathy.CONCLUSION: The orthopedic surgeon accompanies the patient and family through all stages of the disease and must be appropriately informed on current management and treatment strategies even outside the limits of the personal field of specialization.
引用
收藏
页码:636 / 642
页数:6
相关论文
共 50 条
  • [22] Duchenne muscular dystrophy
    Yiu, Eppie M.
    Kornberg, Andrew J.
    NEUROLOGY INDIA, 2008, 56 (03) : 236 - 247
  • [23] Pathophysiology of duchenne muscular dystrophy: Current hypotheses
    Deconinck, Nicolas
    Dan, Bernard
    PEDIATRIC NEUROLOGY, 2007, 36 (01) : 1 - 7
  • [24] Duchenne muscular dystrophy: current cell therapies
    Sienkiewicz, Dorota
    Kulak, Wojciech
    Okurowska-Zawada, Bozena
    Paszko-Patej, Grazyna
    Kawnik, Katarzyna
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (04) : 166 - 177
  • [25] CURRENT STATUS OF DUCHENNE MUSCULAR-DYSTROPHY
    IANNACCONE, ST
    PEDIATRIC CLINICS OF NORTH AMERICA, 1992, 39 (04) : 879 - 894
  • [26] Current treatment of adult Duchenne muscular dystrophy
    Wagner, Kathryn R.
    Lechtzin, Noah
    Judge, Daniel P.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (02): : 229 - 237
  • [27] Duchenne Muscular Dystrophy
    Kernich, Catherine A.
    NEUROLOGIST, 2009, 15 (06) : 373 - +
  • [28] Duchenne Muscular Dystrophy
    Sanders, Mark A.
    Towbin, Richard B.
    Schaefer, Carrie M.
    Li, Yinan
    Towbin, Alexander J.
    APPLIED RADIOLOGY, 2023, 52 (02) : 33 - 35
  • [29] Duchenne muscular dystrophy
    Duan, Dongsheng
    Goemans, Nathalie
    Takeda, Shin'ichi
    Mercuri, Eugenio
    Aartsma-Rus, Annemieke
    NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
  • [30] Biomarkers of Duchenne muscular dystrophy: current findings
    Szigyarto, Cristina Al-Khalili
    Spitali, Pietro
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2018, 8 : 1 - 13